20 August 2026
New Hope for Dementia with Lewy Bodies and Liver Cancer Treatments
The UK's licensing pathway has fast-tracked promising new investigational treatments for dementia with Lewy bodies and liver cancer.

The UK has fast-tracked two promising new investigational treatments for liver cancer and progressive dementia with Lewy bodies.
What These New Treatments Mean

- Dementia with Lewy bodies is a complex, progressive neurological condition affecting many families.
- Hepatocellular carcinoma is the most common form of liver cancer in the UK.
- Innovation Passports speed up regulatory guidance to help get safe drugs to patients sooner.
- Both treatments are still in development and require final evidence of safety and effectiveness.
Next Steps and Key Dates
- Future availability depends on final testing to prove clinical safety and value.
- Drug developers can apply for the next licensing round until 4 November 2026.
- Detailed guidance for innovative medicine applications is available on the MHRA website.
Source: www.gov.uk
